2021-07-29 22:51:04 +00:00
|
|
|
|
:PROPERTIES:
|
|
|
|
|
|
:ID: f94cbbe7-8a99-47ee-8a11-51e4f1295b81
|
|
|
|
|
|
:ROAM_REFS: cite:MatsHolmberg1970
|
|
|
|
|
|
:ROAM_ALIASES: "Holmberg et al., 2018"
|
|
|
|
|
|
:END:
|
2020-07-29 05:37:16 +00:00
|
|
|
|
#+TITLE: Supporting sexuality and improving sexual function in transgender persons
|
|
|
|
|
|
|
|
|
|
|
|
* Excerpts
|
|
|
|
|
|
|
|
|
|
|
|
#+begin_quote
|
|
|
|
|
|
For some transgender women, low sexual desire can lead to personal or relational
|
|
|
|
|
|
distress, fulfilling the diagnostic criteria for hypoactive sexual desire
|
|
|
|
|
|
disorder (HSDD).
|
|
|
|
|
|
#+end_quote
|
|
|
|
|
|
|
|
|
|
|
|
#+begin_quote
|
|
|
|
|
|
For transgender women who wish to maintain erectile ability, occurrence of
|
|
|
|
|
|
nocturnal and spontaneous erections might, therefore, be important, and can be
|
|
|
|
|
|
supported by low-dose testosterone and/or the use of phosphodiesterase type 5
|
2021-07-29 22:51:04 +00:00
|
|
|
|
(PDE5) inhibitors. ([[id:c5a7e1c9-04e6-4f3c-a5bb-7443fce82fd7][Isidori et al., 2013]])
|
2020-07-29 05:37:16 +00:00
|
|
|
|
#+end_quote
|
